NCT02635945View on ClinicalTrials.gov

A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

November 30, 2019

Conditions
Asthma
Interventions
DRUG

PBF-680

DRUG

Placebo

Trial Locations (1)

08025

Unitat de Pneumologia Experimental, Barcelona

All Listed Sponsors
collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

collaborator

Hospital de Sant Pau

OTHER

lead

Palobiofarma SL

INDUSTRY

NCT02635945 - A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients. | Biotech Hunter | Biotech Hunter